Phenotypic and genetic changes in coxsackievirus B5 following repeated passage in mouse pancreas in vivo

Journal of Medical Virology

Volumn 75, Issue 4, 2005, Pages 566-574

  Al Hello, Haider ^a   Davydova, Berta ^a   Smura, Teemu ^a   Kaialainen, Svetlana ^a   Ylipaasto, Petri ^a   Saario, Elise ^a   Hovi, Tapani ^a   Rieder, Elizabeth ^b   Roivainen, Merja ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

Author keywords

Chronic inflammation; Coxsackievirus; Enterovirus; Genetic determinants; Increased blood glucose; Mouse pancreas; Repeated passages

Indexed keywords

AMINO ACID; CAPSID PROTEIN; NUCLEOTIDE;

ADAPTATION; ADOLESCENT; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CHRONIC PANCREATITIS; CONTROLLED STUDY; COXSACKIE VIRUS B; COXSACKIE VIRUS B5; DIABETES LIKE SYNDROME; DIABETOGENIC STRAIN; EXPERIMENTAL INFECTION; GENETIC MARKER; GENOTYPE; GLUCOSE METABOLISM; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PANCREAS; PANCREAS ACINUS; PANCREAS ISLET BETA CELL; PHENOTYPE; TISSUE SPECIFICITY; VIRUS STRAIN;

ANIMALS; BLOOD GLUCOSE; CHRONIC DISEASE; ENTEROVIRUS B, HUMAN; ENTEROVIRUS INFECTIONS; GENOTYPE; INFLAMMATION; MALE; MICE; PANCREAS; PHENOTYPE; SERIAL PASSAGE;

EID: 14344251703     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20303     Document Type: Article

References (35)

1. Andreoletti L, Hober D, Hober-Vandenberghe C, Belaich S, Vantyghem M-C, Lefebvre J, Wattre P. 1997. Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type I diabetes mellitus. J Med Virol 52:121-127.
2. Arola A, Kalimo H, Ruuskanen O, Hyypia T. 1995. Experimental myocarditis induced by two different coxsackievirus B3 variants: Aspects of pathogenesis and comparison of diagnostic methods. J Med Virol 47:251-259.
3. Bae YS, Yoon JW. 1993. Determination of diabetogenicity attributable to a single amino acid, Ala776, on the polyprotein of encephalomyocarditis virus. Diabetes 42:435-443.
4. Caggana M, Chan P, Ramsingh A. 1993. Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. J Virol 67:4797-4803.
5. Champsaur H, Dussaix E, Samolyk D, Fabre M, Bach C, Assan R. 1980. Diabetes and Coxsackie virus B5 infection. Lancet 1:251.
6. Chehadeh W, Weill J, Vantyghem MC, Alm G, Lefebvre J, Wattre P, Hober D. 2000. Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: Relationship with coxsackievirus B infection. J Infect Dis 181:1929-1939.
7. Clements GB, Galbraith DN, Taylor KW. 1995. Coxsackie B virus infection and onset of childhood diabetes. Lancet 346:221-223.
8. Craig ME, Howard NJ, Silink M, Rawlinson WD. 2003. Reduced frequency of HLA DRB1*03-DQB1*02 in children with type 1 diabetes associated with enterovirus RNA. J Infect Dis 187:1562-1570.
9. Flodstrom M, Maday A, Balakrishna D, Cleary MM, Yoshimura A, Sarvetnick N. 2002a. Target cell defense prevents the development of diabetes after viral infection. Nat Immunol 3:373-382.
10. Flodstrom M, Shi FD, Sarvetnick N, Ljunggren HG. 2002b. The natural killer cell-friend or foe in autoimmune disease? Scand J Immunol 55:432-441.
11. Flodstrom M, Tsai D, Fine C, Maday A, Sarvetnick N. 2003. Diabetogenic potential of human pathogens uncovered in experimentally permissive beta-cells. Diabetes 52:2025-2034.
12. Hiltunen M, Hyoty H, Leinikki P, Study Group Childhood Diabetes F. 1991. Dime Project Defective Antibody Reactivity to Mumps Virus Antigen in Type I Diabetes. 26th Annual Meeting Of The Scandinavian Society For The Study Of Diabetes, Helsinki, Finland, May, Vol. 124.15 p.
13. Hiltunen M, Hyoty H, Knip M, Ilonen J, Reijonen H, Vahasalo P, Roivainen M, Lonnrot M, Leinikki P, Hovi T, Akerblom HK. 1997. Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. Childhood Diabetes in Finland (DiMe) Study Group. J Infect Dis 175:554-560.
14. Horwitz MS, Ilic A, Fine C, Rodriguez E, Sarvetnick N. 2003. Coxsackievirus-mediated hyperglycemia is enhanced by reinfection and this occurs independent of T cells. Virology 314:510-520.
15. Hyoty H, Hiltunen M, Knip M, Laakkonen M, Vahasalo P, Karjalainen J, Koskela P, Roivainen M, Leinikki P, Hovi T, Averblom HK, and the Childhood Diabetes in Finland (DTHE) Study Group. 1995. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes 44:652-657.
16. Jun HS, Kang Y, Notkins AL, Yoon JW. 1997. Gain or loss of diabetogenicity resulting from a single point mutation in recombinant encephalomyocarditis virus. J Virol 71:9782-9785.
17. Klingel K, Stephan S, Sauter M, Zell R, McManus BM, Bultmann B, Kandolf R. 1996. Pathogenesis of murine enterovirus myocarditis: Virus dissemination and immune cell targets. J Virol 70:8888-8895.
18. Knowlton KU, Jeon ES, Berkley N, Wessely R, Huber S. 1996. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J Virol 70:7811-7818.
19. Mena I, Fischer C, Gebhard JR, Perry CM, Harkins S, Whitton JL. 2000. Coxsackievirus infection of the pancreas: Evaluation of receptor expression, pathogenesis, and immunopathology. Virology 271:276-288.
20. Muckelbauer JK, Kremer M, Minor I, Diana G, Dutko FJ, Groarke J, Pevear DC, Rossmann MG. 1995. The structure of coxsackievirus B3 at 3.5 A resolution. Structure 3:653-667.
21. Ramsingh AI, Chapman N, Tracy S. 1997. Coxsackieviruses and diabetes. BioEssays 19:793-800.
22. Roivainen M, Knip M, Hyoty H, Kulmala P, Hiltunen M, Vahasalo P, Hovi T, Akerblom HK. 1998. Several different enterovirus serotypes can be associated with prediabetic autoimmune episodes and onset of overt IDDM. Childhood Diabetes in Finland (DiMe) Study Group. J Med Virol 56:74-78.
23. Ross ME, Hayashi K, Notkins AL. 1974. Virus-induced pancreatic disease: Alterations in concentration of glucose and amylase in blood. J Infect Dis 129:669-676.
24. Schmidtke M, Selinka HC, Heim A, Jahn B, Tonew M, Kandolf R, Stelzner A, Zell R. 2000. Attachment of coxsackievirus B3 variants to various cell lines: Mapping of phenotypic differences to capsid protein VP1. Virology 275:77-88.
25. See DM, Tilles JG. 1995. Pathogenesis of virus-induced diabetes in mice. J Infect Dis 171:1131-1138.
26. Szopa TM, Dronfield DM, Ward T, Taylor KW. 1989. In vivo infection of mice with Coxsackie B4 virus induces long-term functional changes in pancreatic islets with minimal alteration in blood glucose. Diabet Med 6:314-319.
27. Toniolo A, Onodera T, Jordan G, Yoon JW, Notkins AL. 1982. Virus-induced diabetes mellitus. Glucose abnormalities produced in mice by the six members of the Coxsackie B virus group. Diabetes 31:496-499.
28. Vella C, Brown CL, McCarthy DA. 1992. Coxsackievirus B4 infection of the mouse pancreas: Acute and persistent infection. J Gen Virol 73:1387-1394.
29. Vuorinen T, Kallajoki M, Hyypia T, Vainionpaa R. 1989. Coxsackievirus B3-induced acute pancreatitis: Analysis of histopathological and viral parameters in a mouse model. Br J Exp Pathol 70:395-403.
30. Yap IS, Giddings G, Pocock E, Chantler JK. 2003. Lack of islet neogenesis plays a key role in beta-cell depletion in mice infected with a diabetogenic variant of coxsackievirus B4. J Gen Virol 84:3051-3068.
31. Yin H, Berg AK, Tuvemo T, Frisk G. 2002. Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of type 1 diabetic children at onset. Diabetes 51:1964-1971.
32. Ylipaasto P, Klingel K, Lindberg AM, Otonkoski T, Kandolf R, Hovi T, Roivainen M. 2004. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 47:225-239.
33. Yoon JW, Onodera T, Notkins AL. 1978. Virus-induced diabetes mellitus. XV. Beta cell damage and insulin-dependent hyperglycemia in mice infected with coxsackie virus B4. J Exp Med 148:1068-1080.
34. Yoon JW, London WT, Curfman BL, Brown RL, Notkins AL. 1986. Coxsackie virus B4 produces transient diabetes in nonhuman primates. Diabetes 35:712-716.
35. Yoon JW, Ihm SH, Kim KW. 1989. Viruses as a triggering factor of type 1 diabetes and genetic markers related to the susceptibility to the virus-associated diabetes. Diabetes Res Clin Pract 7:S47-S58.